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Although the precise functions of ether phospholipids are still poorly understood, signiﬁcant alterations
in their physiological levels are associated either to inherited disorders or to aggressive metastatic
cancer. The essential precursor, alkyl-dihydroxyacetone phosphate (DHAP), for all ether phospholipids
species is synthetized in two consecutive reactions performed by two enzymes sitting on the inner side
of the peroxisomal membrane. Here, we report the characterization of the recombinant human DHAP
acyl-transferase, which performs the ﬁrst step in alkyl-DHAP synthesis. By exploring several expression
systems and designing a number of constructs, we were able to purify the enzyme in its active form and
we found that it is tightly bound to the membrane through the N-terminal residues.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Ether phospholipids are characterized by an ether bond, rather
than an ester bond, on the sn-1 position of the glycerol backbone.
Although the detailed physiological roles of intracellular and
circulating ether linked phospholipids are not yet well understood,
their peculiar physical properties impact on many aspects of cell
signaling and membrane biology [1,2]. In addition to their impor-
tance as structural components of cell membranes, they are
fundamental for membrane fusion and vesicle formation, and they
are involved in free radical scavenging and secondmessenger lipids
storage [3,4]. Their importance is further underlined by the path-
ological conditions associated to altered synthesis. In fact, most of
the known peroxisomal disorders show deﬁcient ether lipids syn-
thesis [5,6]. Additionally, elevated ether lipids synthesis and uptake
are a characteristic metabolic aberration of certain type of aggres-
sive cancers, contributing to their invasiveness and survival [7].
The key enzymes involved in the ether phospholipids biosyn-
thetic pathway, namely dihydroxyacetone phosphate acyl-
transferase (DHAPAT) and alkyl-dihydroxyacetone phosphate syn-
thase (ADPS), catalyze the acylation of dihydroxyacetone phos-
phate (DHAP) to form acyl-DHAP followed by the replacement ofvi).
Inc. This is an open access article uthe acyl moiety with a long fatty alcohol, yielding alkyl-DHAP [8].
Mutations in the genes encoding for DHAPAT and ADPS cause a rare
inherited peroxisomal disorder, rhizomelic chondrodysplasia
punctata (RCDP). RCDP patients show skeletal dysplasia and pro-
found mental retardation, which in most of the cases lead to pre-
mature death [9].
Whereas the unusual reaction mechanism of ADPS ﬂavin fueled
the interest in the biochemical characterization of this enzyme
[10e12], the difﬁculties associated to DHAPAT expression and pu-
riﬁcation slowed progress for decades. DHAPAT performs the ﬁrst
step of the ether phospholipid biosynthetic pathway, namely the
acylation of DHAP to form acyl-DHAP, which is the substrate of the
downstream ADPS reaction. The peroxisomal localization of DHA-
PAT is crucial for its enzymatic activity and stability, and it is ach-
ieved by the presence of the peroxisomal targeting signal-1 (PTS1)
at the C-terminus of its amino acid sequence [13]. For long, the
organization of the gene encoding for DHAPAT has remained un-
determined [14], although the protein itself was isolated from hu-
man placenta [15] and guinea pig liver [16] as a 680 amino acid
enzyme with a molecular mass of 77 kDa [17]. In vivo experiments
suggested that DHAPAT activity was dependent on the presence of
ADPS. In particular, kinetic experiments indicated that endoge-
nously generated acyl-DHAP was used preferentially by ADPS in
comparison with exogenously added substrate, suggesting a close
interaction of the two enzymes within the peroxisomes [18,19]. The
formation of DHAPAT/ADPS complex was initially characterized bynder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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peroxisomes, and this remains the only evidence of the hetero-
trimeric complex formation so far [20].
The results presented in this study aim to develop a method-
ology to express and purify for the ﬁrst time recombinant human
DHAPAT using P. pastoris to enable the study of its interaction with
ADPS.
2. Materials and methods
2.1. Full-length human DHAPAT in HEK-293E cells: cloning,
expression and puriﬁcation
Human DHAPAT cDNA (NM_014236.3) was supplied by Origene.
N-terminal His8-eGFP tag was fused to DHAPAT through PCR and
cloned into pCDNA3 vector (Invitrogen). HEK-293E (Invitrogen)
cells were grown in suspension according to Longo et al. [21]. The
transfection mixture contained polyethylenimine (PEI;
DNA:PEI ¼ 1:3 w/w), OPTIMEM medium (Gibco, 1:20 v/v) and
pCDNA3-His8-eGFP-DHAPAT (1 mg of DNA/106 cells). Cells were
collected after 24/48 h after transfection. Frozen cell pellets were
resuspended in hypotonic buffer (10 mM Tris-HCl pH 7.5, 1 mM
EDTA) with protease inhibitors Complete EDTA-Free (Roche), 1 mM
PMSF, and 1mg/ml DNAse, and homogenized on ice 30 timeswith a
tight pestle. The sample was centrifuged at 70,000g for 1 h. Cell
membranes were resuspended in 30 mM HEPES pH 7.8, 500 mM
NaCl, 50% glycerol, and protease inhibitors. Solubilization was
performed adding 1% of detergent (Anatrace) and stirring 2 h at
4 C followed by centrifugation at 70,000g for 1 h. Fluorescence
size-exclusion chromatography (F-SEC) experiment was performed
according to Goering et al., 2014 [22], using a Superdex 75 5/150
column (GE Healthcare) and a Schimadzu HPLC system equilibrated
with 30 mM HEPES pH 7.8, 500 mM NaCl, 5% glycerol and 0.03%
DDM.
2.2. Bioinformatic analysis of DHAPAT amino acid sequence
The secondary structure prediction resulted from the compari-
son of the following servers: HHpred, Quick2D [23], PredictProtein
[24], Proteus 2.0 [25]. The transmembrane (TM) helices/region
prediction was performed by interrogating the following servers:
POLYVIEW-2D (117e138) [26], TMAP (115e132,168e196, 370e398,
565e580) [27], TMPRED (8e25, 165e194) [28], Octopus (510e560)
[29].
2.3. Human DHAPAT deletion mutants: cloning, expression and
puriﬁcation in E. coli cells
DHAPAT shorter constructs were obtained by PCR, either lack-
ing of N-terminal portions (DHAPATD120, DHAPATD135, DHA-
PATD144, DHAPATD150, DHAPATD156, DHAPATD285,
DHAPATD530) or single domains (DHAPAT144-530, DHAPAT156-
530, DHAPAT1-163), and cloned in pET28 vectors (Novagen) con-
taining PreScission protease cleavable N-terminal tags (His8-
SUMO, GST and His8-eGFP). Expression trials were performed in
BL21, Origami, Rosetta, DH5a, Rosetta-gami and C41 E. coli strains
(Novagen). GST-DHAPATD135 expressed using Origami was chosen
for further expression and puriﬁcation experiments. The culture
was grown at 37 C and 200 rpm in TB medium (Terriﬁc Broth)
until OD600 of 1 and induced by adding 500 mM isopropyl-b-D-1-
thiogalactopyranoside, shifting the temperature to 17 C for
20 h. Collected cells were resuspended in 50 mM Tris-HCl pH 8.0,
500 mM NaCl, 5% glycerol, protease inhibitors Complete EDTA-
Free (Roche), 1 mM PMSF, and 1 mg/ml DNAse. Resuspended
cells were disrupted by sonication and centrifuged at 70,000g for40 min at 4 C. The soluble fraction was loaded on a 5 ml GSTrap
FF pre-packed column (GE Healthcare), equilibrated with lysis
buffer, using the €AKTA FPLC system (GE Healthcare), and eluted
with 50 mM of reduced glutathione. The sample was incubated at
4 C with GST-tagged PreScission protease, 1:100 v/v overnight.
Tag and protease were removed in a second run with the GST-trap
column. The fractions containing the protein were pooled and
loaded on an ion-exchange column (SOURCE 15Q, GE Healthcare),
followed by a size-exclusion chromatography step (Superdex 200
10/300, GE Healthcare).2.4. Full-length human DHAPAT: cloning, expression and
puriﬁcation in P. pastoris cells
Human DHAPAT cDNA fused with a N-terminal His8-GFPuv
(PreScission protease cleavable) and codon-optimized for
P. pastoris expression was purchased from DNA2.0, and sub-cloned
in the pJexpress 902 (DNA2.0) vector. The resulting plasmid was
linearized using SacI enzyme (Thermo Scientiﬁc). The trans-
formation was performed according to Lin-Cereghino et al. [30],
using P. pastoris KM71H MutS strain (Invitrogen). The colonies
were tested for DHAPAT expression by inoculating them in 24
deep-well plates containing 2 ml of BMGY medium (100 mM
HK2PO4 pH 6.0, 6.34% Yeast Nitrogen Base, 1% glycerol, 4  105%
biotin), incubating at 30 C, 280 rpm for 60 h. The medium was
exchanged with BMM medium (100 mM HK2PO4 pH 6.0, 6.34%
Yeast Nitrogen Base, 0.5% methanol, 4  105% biotin) to induce
protein expression, and after 48 h GFPuv ﬂuorescence was
measured with a Clariostar plate reader (BMG Labtech; excitation
395 nm, emission 509 nm). Positive clones were inoculated in
15 ml of BMGY medium. The pre-inoculum was incubated for
30 min at 30 C (300 rpm). 2.5 ml of the pre-inoculum was poured
in 2 L bafﬂed-ﬂask containing 200 ml of BMGY medium, and
incubated for 72 h at 30 C (280 rpm). Cells were harvested at
1500 g for 10 min and resuspended in 100 ml of BMM medium. To
allow the induction to continue for 72 h, 0.5% methanol was added
every 24 h. The best expressing clone was grown in a 5 L Bioﬂo
3000 Fermentor (Brunswick) at 30 C and 72 h of methanol in-
duction, according to Damasceno et al., 2004 [31]. Cells were
collected by centrifugation at 1,500g for 10 min at 4 C, resus-
pended in 50 mM Bicine pH 9.0, 500 mM NaCl, 10% glycerol,
protease inhibitors Complete EDTA-Free (Roche), 1 mM PMSF, and
1 mg/ml DNAse, and lysed using a bead beater with zirconia beads
(Biospec). Cell membranes were collected by centrifugation at
70,000g for 2 h at 4 C. F-SEC experiment was performed as
described above [22]. Solubilization was performed by adding 1%
of FSC-12 (Anatrace) to the resuspended membranes (50 mM
Bicine pH 8.2, 150 mM NaCl, 5% glycerol and protease inhibitors),
stirring overnight at 4 C. Solubilized membranes were centri-
fuged at 70,000g for 1.5 h. The supernatant was incubated with
5 ml of slurry Ni-Sepharose resin (GE Healthcare), stirring at 4 C
for 2 h. The buffers used for the washing steps had decreasing
amounts (till 0,05%) of FSC-12. The elution step was performed
using 300 mM of imidazole in the binding buffer. Tag-cleavage was
performed incubating the sample with PreScission protease (GE
Healthcare) in 1:10,000 v/v ratio, overnight at 4 C. The second
afﬁnity chromatography step and the other puriﬁcation steps were
carried out using the €AKTA FPLC (GE Healthcare), loading the
sample on a pre-packed nickel column (His-trap, GE-Healthcare).
The collected fractions were concentrated with the Amicon Ultra
concentrator (30 kDa cutoff). Size-exclusion chromatography was
performed using a Superdex 200 10/300 column (GE Healthcare),
equilibrated with buffer containing 50 mM bicine pH 8.2, 50 mM
NaCl, 5% glycerol and 0.05% FSC-12.
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DHAPAT (50 mM)was incubated for 30min at 25 C with 100 mM
acyl-CoA and 100 mMDHAP (Sigma-Aldrich) in assay buffer (50mM
Tris-HCl pH 8.2, 50 mM NaF, 0.05% v/v FSC-12). Puriﬁed recombi-
nant ADPS (1 mM), prepared according to Nenci et al., 2012 [11], and
the radioactive substrate (100 mM), [1e14C]hexadecyl-DHAP
(Sigma-Aldrich; speciﬁc radioactivity adjusted to 13,000 dpm/
nmol), were added to the protein solution after the incubation.
Once ADPS was added, small aliquots (10 ml) were taken at 1.5 min
intervals and deposited on a DEAE cellulosemembrane (Whatman),
which interact with the phosphate groups of DHAP. After 4
consecutive washings with ethanol 100% to remove the excess of
labeled hexadecanol, the membranes were analyzed at the scin-
tillation counter (Tri-Carb-2100TR, Packard) to quantify the radio-
activity emitted by the immobilized ADPS product. The same
protocol was used to perform the activity assay of human DHA-
PATD135. All the assays were performed in duplicate. The positive
control was performed as described above, using ADPS (1 mM) and
adding 100 mM palmitoyl-DHAP [11].
2.6. Pull-down experiment and native gel electrophoresis
His8-uvGFP-DHAPAT was puriﬁed as described above, without
digesting with PreScission protease, (i.e. retaining the His8-tag).
Puriﬁed ADPS was prepared according to Nenci et al., 2012 [11]. The
two proteins were mixed with nickel-resin, equilibrated with
buffer containing 50 mM bicine pH 8.2, 50 mM NaCl, 5% glycerol
and 0.05% FSC-12. The beads were washed with the same buffer
and the elution was performed with 500 mM imidazole. The
samples for native-PAGE (PhastGEL Native system, GE Healthcare)
were prepared in a total volume of 6 ml (ﬁnal concentration 1 mg/
ml) by adding puriﬁed proteins with different ratios in the buffer
containing 50mMbicine pH 8.2, 50mMNaCl, 5% glycerol and 0.05%
FSC-12.
3. Results and discussion
3.1. DHAPAT is associated to peroxisomal membranes
Recombinant human DHAPAT fused to the green ﬂuorescent
protein (GFP) was expressed in HEK293-E cells retaining the
peroxisomal translocation signal, as no expression was observed
without PTS1 (data not shown). Partial puriﬁcation of the enzyme
revealed that DHAPAT is tightly associated to the membrane frac-
tion. It was already observed that DHAPAT localizes in the inner
side of the peroxisomal membrane, although there were no evi-
dences of transmembrane regions [20]. Indeed, detergents were
necessary to isolate DHAPAT, as neither glycerol nor high salt
concentration were enough to solubilize it (Fig. 1A). Using a small
panel of commonly used detergents, it was possible to recover up to
80% of the total GFP ﬂuorescence, whereas with buffer without
detergents the ﬂuorescence was still associated to the membrane
fraction (Fig. 1B). The SDS-PAGE analysis showed that detergents
solubilized a ﬂuorescent band in correspondence of the expected
molecular weight of DHAPAT with the GFP tag (Fig. 1C). To deter-
mine the aggregation state of solubilized DHAPAT and to identify a
suitable detergent for the puriﬁcation, we performed a ﬂuores-
cence size-exclusion chromatography (F-SEC) experiment. The re-
sults of F-SEC revealed that DHAPAT behaves very differently
according to the detergent, and that most of the solubilized protein
is homogenous and not aggregated (Fig. 1D). However, the scale-up
of DHAPAT expression and puriﬁcation from HEK293-E cells
resulted difﬁcult, as the protein was unstable and challenging to
purify due to both low solubilization yields and poor interactionswith afﬁnity resins. We assumed that this is caused by mis-
translocation in peroxisomes consequent to DHAPAT over-
expression. Indeed, we observed that HEK-293E cells showed the
formation of large ﬂuorescence lysosomes at post-transfection time
above the 48 h, likely due to mis-folded DHAPAT accumulation
(data not shown).
3.2. The region associated with membranes is located at the N-
terminus of DHAPAT
Bioinformatics analysis of DHAPAT sequence did not provide
reliable tertiary structure prediction, as there are no crystal struc-
tures available of similar enzymes. Indeed, it was not even possible
to predict the domain organization of the enzyme because the only
conserved region is the putative acyl-transferase domain, spanning
approximately from residue 138 to 283 [32,33]. By interrogating
several types of software (see Materials and Methods section) to
predict the secondary structures of DHAPAT, we identiﬁed a num-
ber of highly hydrophobic a-helices, which could either be part of
the active site, expected to be partially hydrophobic to host the
substrate acyl chain, or interact with the peroxisomal membrane
(in green in Fig. 2A). Based on these predictions, we designed a
number of shorter DHAPAT constructs with the aim of obtaining a
soluble portion of the protein both to pinpoint membrane-
interaction sites and favor crystallographic studies.
We used E. coli as expression system to screen short protein
variants fused to puriﬁcation tags known to help the folding and
protein solubility (i.e. SUMO and GST). DHAPATD135, DHAPATD144,
DHAPATD150, lacking of N-terminal segments of different lengths,
were expressed and, in particular, we succeeded in obtaining a
soluble and puriﬁable form of DHAPAT lacking the ﬁrst 135 amino
acids, fused to GST tag. Although the expression yield was good and
it was possible to purify DHAPATD135 without the use of de-
tergents, the protein was unstable and highly prone to aggregation
(Fig. 2BeC). Indeed, the non-functional state of the protein was
conﬁrmed both by the SEC proﬁle, which showed that most of the
proteinwas aggregated, and by the activity assay, that revealed that
DHAPATD135 is completely inactive (Fig. 2D). Nevertheless these
experiments were insightful as they indicate that the N-terminal
segment is a main element for membrane association/integration and
that this portion is likely involved in the enzymatic activity and in the
correct protein folding.
3.3. Recombinant human full-length DHAPAT puriﬁed from
P. pastoris retains the enzymatic activity
As membrane association resulted to be essential for correct
DHAPAT function, we focused on the characterization of the full-
length enzyme. It was already observed that the localization of
DHAPAT in peroxisomes is crucial for its correct function and ac-
tivity. Therefore, we chose P. pastoris as a eukaryotic expression
system, given its characteristic peroxisomes proliferation under
methanol induction of heterologous proteins expression [34]. As in
the case of HEK-293E cells, we retained the PTS1 signal andwe used
the C-terminal sequence SKL, instead of the human AKL, because it
is recognized more efﬁciently by yeast. The expression yield in
P. pastoris of human DHAPAT was much higher than in mammalian
cells and the protein was still tightly associated to the organelle
membranes. We used F-SEC to evaluate the quality and the yield of
protein solubilized using a large number of detergents. Only
foscholine-12 (FSC-12) appeared to extract good amounts of pro-
tein, whereof only approximately 50% was in a non-aggregated
form (Fig. 3A). DHAPAT was then puriﬁed through two steps of
afﬁnity chromatography to remove the tag after the cleavage,
resulting in a pure sample which was further conﬁrmed by the SEC
Fig. 1. Recombinant human DHAPAT expression in HEK-293E cells. (A) Fluorescence of samples treated with buffers containing different combinations of chaotropic agents (A -
50 mM NaCl and 30% glycerol, B - 50 mM NaCl and 20% glycerol, C - 50 mM NaCl and 5% glycerol, D e 1 M NaCl and 30% glycerol, E e 1 M NaCl and 5% glycerol, F e 500 mM NaCl and
30% glycerol, G e 500 mM NaCl and 5% glycerol) to increase eGFP-DHAPAT solubility after cell lysis. (B) eGFP-DHAPAT ﬂuorescence recovered after solubilization with or without
detergents. (C) eGFP ﬂuorescence detection in SDS-PAGE. The ﬂuorescent band corresponds to the expected molecular weight of DHAPAT fused to eGFP (109 kDa, considering that
membrane proteins migrate with a discrepancy of up to the 30% of the expected molecular weight, due to the interaction with detergent micelles [35]). (D) F-SEC proﬁle su-
perposition representing the best detergents for human DHAPAT solubilization from HEK-293E cells.
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yield of puriﬁed DHAPATwas approximately 1 mg from 0.15 l of cell
culture (corresponding to 50 g of wet cells) grown at high cell
density with the fermenter. To assess whether the puriﬁed re-
combinant human DHAPAT was retaining its enzymatic activity, we
used its partner, ADPS. This assay established is inherently very
speciﬁc, because it is based on the accumulation of palmitoyl-DHAP
produced by DHAPAT, which is used by ADPS to form alkyl-DHAP.
First, DHAPAT was incubated with its substrates, palmitoyl-CoA
and DHAP. Then, ADPS and its radioactively labeled substrate,
[1e14C]hexadecanol, were added and production of [1e14C]hex-
adecyl-DHAP was monitored. As control, we performed the same
experiment without DHAPAT (Fig. 3D). These experiments clearly
indicated that there was acyltransferase activity and conﬁrmed that,
for the ﬁrst time, we could produce a recombinant pure DHAPAT able
to convert acyl-CoA to acyl-DHAP.3.4. Reconstitution of the putative DHAPAT-ADPS enzymatic
complex
In order to improve the expression and the puriﬁcation, we
initially tried to co-express DHAPAT with ADPS in HEK-293E cells,
as it is known that DHAPAT activity and stability is dependent on
ADPS presence [19]. While we succeeded in the co-expression, we
could not co-purify the two enzymes, possibly because ADPS is
negatively affected by the presence of high concentration of de-
tergents needed for DHAPAT solubilization (see Fig. 4A). Therefore,
we exploited the results obtained using P. pastoris expression sys-
tem, which allowed us to obtain pure and active recombinant hu-
man DHAPAT. However, we could not obtain clear results from
classic pull-down and size-exclusion chromatography experiments,
due to the presence of FSC-12, which was found to cause aggre-
gation and degradation of ADPS making chromatographic experi-
ments unusable (Fig. 4A). Indeed, we observed that ADPS was not
Fig. 2. Characterization of recombinant human DHAPATD135. (A) Prediction of the secondary structure organization of DHAPAT. Based on the hydropathy plot and the hy-
drophobic nature of the amino acids included in predicted a-helices (115e132, 168e178, 409e425, 464e481, 565e580, 600e624), we identiﬁed putative portions interacting with
the peroxisomal membrane. (B) Size-exclusion chromatography elution proﬁle of puriﬁed DHAPATD135 shows a major peak at 8.6 ml, corresponding to the void volume of the
column and a minor peak at 14 ml, which corresponds to approximately 60 kDa size, the expected size of DHAPATD135 (54 kDa). (C) The purity of DHAPAT sample after SEC is
conﬁrmed by SDS-PAGE, showing a single band corresponding to approximately 60 kDa. (D) Radioactivity assay based on ADPS coupled-reaction shows that DHAPATD135 is not
active, as it did not produce palmitoyl-DHAP, the ADPS substrate. ADPS alone with DHAPAT substrates was used as negative control and ADPS with palmitoyl-DHAP (DHAPAT
product) as positive control.
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two distinct fragments.On the other hand, we obtained interesting results using native
gel electrophoresis. To demonstrate that the interaction between
Fig. 3. Full-length recombinant human DHAPAT expression and puriﬁcation from P. pastoris. (A) Superposition of all elution proﬁles of solubilized DHAPAT shows that DHAPAT
from P. pastoris is mainly aggregated with most detergents. (B) Size-exclusion chromatography elution proﬁle of puriﬁed DHAPAT in complex with FSC-12 micelles (19 kDa) shows a
single monodisperse peak at 10.4 ml (void volume 8.9 ml). (C) The purity of DHAPAT sample after SEC is conﬁrmed by SDS-PAGE, showing a single band corresponding to
approximately 70 kDa. (D) Radioactivity assay based on the production of radioactive alkyl-DHAP by ADPS, using acyl-DHAP produced by DHAPAT. The negative control was
performed incubating acyl-CoA and DHAP without DHAPAT. Incubation of ADPS with palmitoyl-DHAP (DHAPAT product) was the positive control.
V. Piano et al. / Biochemical and Biophysical Research Communications 481 (2016) 51e5856ADPS and DHAPAT was not due to the experimental conditions, a
control using the soluble protein 7b-hydroxysteroid dehydrogenase
was performed (Fig. 4B). The native gel clearly showed that, when
ADPS and DHAPAT were mixed together, a new band was detected,
which was different from the bands appearing from the migrationof the single proteins. Moreover, no new band was detected when
DHAPAT was mixed with the control dehydrogenase protein. The
results obtained from the native gel suggested that, for the ﬁrst time,
there was a promising evidence for the formation of the complex be-
tween ADPS and DHAPAT. However, we could not conﬁrm the evidence
Fig. 4. Recombinant ADPS and DHAPAT interaction in vitro. (A) SDS-page of pull-down experiments between ADPS and His8-GFPuv-DHAPAT. 1, sample before incubating with
resin; 2e4, unbound fractions containing manly ADPS; 5, elution with 500 mM imidazole, containing both ADPS and DHAPAT; 6e8, ADPS in buffer containing FSC-12 after 10, 20,
30 min, respectively. After 30 min incubation in FSC-12, ADPS gives rise to two new bands of 40 kDa and 20 kDa. (B) Interaction between APDS and DHAPAT analyzed by native-
PAGE. 1, ADPS þ DHAPAT (1:1); 2, ADPS þ DHAPAT (2:1); 3, DHAPAT; 4, ADPS; 5, DHAPAT þ control protein; 6, control protein.
V. Piano et al. / Biochemical and Biophysical Research Communications 481 (2016) 51e58 57of complex formation with any other technique, as also cross-linking
was impaired by the presence of the detergent.
In summary, we provide the ﬁrst detailed experimental protocol
to produce the recombinant human DHAPAT from P. pastoris, which
could be used for further biochemical and functional studies.
Indeed, the puriﬁed DHAPAT shows enzymatic activity that has
been conﬁrmed by reproducing in vitro the two-steps reaction
performed by DHAPAT and ADPS crucial for ether phospholipids
synthesis.
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